Citation

Vaulin S. Psychiatr. Danub. 2006; 18(Suppl 1): 153.

Affiliation

Smolenk State Medical Academy, 214000 Smolensk, Russia.

Copyright

(Copyright © 2006, Facultas Universitatis Studiorum Zagrabiensis - Danube Symposion of Psychiatry)

DOI

unavailable

PMID

16964167

Abstract

Availability of pharmacological agents is a high-prevalence factor in suicidal poisonings. The aim of this study is optimization of diagnostics and therapy of suicidal poisonings with the further development of adequate prevention. Poisoning is one of the most frequent suicide styles, the contribution of pharmacological poisoning is more then 65%. 1872 cases of suicidal poisonings were studied from 1994 to 2004 (Smolensk, Russia, population 350 thousands). The peak of suicidal poisoning (SP) was in 1994-1997. By 2001 the rate of suicidal poisoning had decreased and then their number became stable. SP was more prevalent among women then men with the average proportion 3-4:1, especially at the age of 15-19 y.o. (8,7:1) and after 60 y.o. (3,5:1). 60% of poisonings were committed at the age of 15-29 (women peak - 20 y.o; men - 25 y.o.). The number of benzodiazepine, tricyclic antidepressants poisoning decreased but the number of antihistaminic poisoning increased twice. The decision to commit poisoning correlated with the seriousness of will, the duration of presuicide, personality, age, sex and cultural peculiarities. Obtained data helps to detect people with the high suicide risk and to measure suicide risk. The use of SSRI and double-acting antidepressants increases the safety of the therapy, and helps to avoid drugs interaction, since for 46% of suicides over the age of 60 are disabled due to somatic disorders.

Language: en